Hypera S.A.
B3:HYPE3.SA
Overview | Financials
Company Name | Hypera S.A. |
Symbol | HYPE3.SA |
Currency | BRL |
Price | 25.94 |
Market Cap | 16,400,764,634 |
Dividend Yield | 3.99% |
52-week-range | 25.87 - 37.18 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Breno Toledo Pires de Oliveira |
Website | https://www.hyperapharma.com.br |
An error occurred while fetching data.
About Hypera S.A.
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD